Literature DB >> 33068223

Amelioration of oxidative stress and neuroinflammation in lipopolysaccharide-induced memory impairment using Rosmarinic acid in mice.

Chetan Thingore1, Viplav Kshirsagar1, Archana Juvekar2.   

Abstract

Oxidative stress plays a pivotal part in the manifestation of neuroinflammation, which further leads to neurodegenerative diseases like Alzheimer's disease (AD). Systemic administration of lipopolysaccharide (LPS) induces neuroinflammation resulting in memory impairment (MI) and cognitive decline. In this study, we evaluated whether prophylactic administration of Rosmarinic acid (RA), a naturally occurring compound, exerts a neuroprotective effect in LPS-induced MI and cognitive decline. Herein, Swiss albino mice were pre-treated with RA (0.5 mg/kg and 1 mg/kg i.p.) for 28 days and were intermittently exposed to LPS (0.25 mg/kg i.p.) for 7 days. LPS caused poor memory retention and increased cognitive decline in Morris water maze (MWM) and Y maze paradigms respectively. Additionally, LPS increased oxidative stress which was denoted by a decrease in superoxide dismutase (SOD) activity, decrease in reduced glutathione (GSH) levels, and increased lipid peroxidation in the brain. Imbalance in the cholinergic system was analyzed by measuring the acetylcholinesterase (AChE) activity. Pre-treatment with RA improved memory and behavioral disturbances by alleviating oxidative stress and AChE activity. LPS augmented levels of tumor necrosis factor (TNF-α), interleukin (IL)-6, caspase-3, and c-Jun. Pre-treatment with RA revitalized the elevated levels of proinflammatory cytokines and apoptotic proteins. In conclusion, this study showcases the amelioration of MI by RA in LPS-challenged memory and cognitive decline, which could be credited to its anti-oxidant effect, inhibitory effect on both proinflammatory cytokines and apoptotic regulators, and reduction in AChE activity.

Entities:  

Keywords:  Alzheimer’s disease; Memory impairment; Neuroinflammation; Rosmarinic acid

Year:  2020        PMID: 33068223     DOI: 10.1007/s11011-020-00629-9

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  113 in total

1.  The neuroprotective effect of vitamin E on chronic sleep deprivation-induced memory impairment: the role of oxidative stress.

Authors:  Karem H Alzoubi; Omar F Khabour; Baraa Abu Rashid; Imad M Damaj; Heba A Salah
Journal:  Behav Brain Res       Date:  2011-09-16       Impact factor: 3.332

2.  Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.

Authors:  Aparna Areti; Prashanth Komirishetty; Anil Kumar Kalvala; Karthika Nellaiappan; Ashutosh Kumar
Journal:  Mol Neurobiol       Date:  2018-02-09       Impact factor: 5.590

3.  Potential Renoprotective Effects of Rosemary and Thyme Against Gentamicin Toxicity in Rats.

Authors:  Amal S Abdel-Azeem; Amany M Hegazy; Hala M Zeidan; Khadiga S Ibrahim; Eman M El-Sayed
Journal:  J Diet Suppl       Date:  2016-12-14

4.  DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay.

Authors:  A J Anderson; J H Su; C W Cotman
Journal:  J Neurosci       Date:  1996-03-01       Impact factor: 6.167

5.  Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer's disease and Lewy body disorders.

Authors:  A S Alexandris; L Walker; A K L Liu; K E McAleese; M Johnson; R K B Pearce; S M Gentleman; J Attems
Journal:  Neuropathol Appl Neurobiol       Date:  2019-10-01       Impact factor: 8.090

6.  Antioxidant activity of rosmarinic acid and its principal metabolites in chemical and cellular systems: Importance of physico-chemical characteristics.

Authors:  Amma G Adomako-Bonsu; Sue Lf Chan; Margaret Pratten; Jeffrey R Fry
Journal:  Toxicol In Vitro       Date:  2017-01-22       Impact factor: 3.500

7.  Oxidative stress in the progression of Alzheimer disease in the frontal cortex.

Authors:  Mubeen A Ansari; Stephen W Scheff
Journal:  J Neuropathol Exp Neurol       Date:  2010-02       Impact factor: 3.685

Review 8.  Cognitive impairment in Parkinson's disease and dementia with Lewy bodies.

Authors:  Dag Aarsland
Journal:  Parkinsonism Relat Disord       Date:  2015-09-21       Impact factor: 4.891

9.  A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Abeta(25-35).

Authors:  Tursun Alkam; Atsumi Nitta; Hiroyuki Mizoguchi; Akio Itoh; Toshitaka Nabeshima
Journal:  Behav Brain Res       Date:  2007-03-12       Impact factor: 3.332

Review 10.  Oxidative toxicity in diabetes and Alzheimer's disease: mechanisms behind ROS/ RNS generation.

Authors:  Waqar Ahmad; Bushra Ijaz; Khadija Shabbiri; Fayyaz Ahmed; Sidra Rehman
Journal:  J Biomed Sci       Date:  2017-09-19       Impact factor: 8.410

View more
  5 in total

Review 1.  The Role of Microbiome in Brain Development and Neurodegenerative Diseases.

Authors:  Varsha Nandwana; Nitesh K Nandwana; Yogarupa Das; Mariko Saito; Tanisha Panda; Sasmita Das; Frankis Almaguel; Narayan S Hosmane; Bhaskar C Das
Journal:  Molecules       Date:  2022-05-25       Impact factor: 4.927

Review 2.  Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.

Authors:  Umair Shabbir; Muhammad Sajid Arshad; Aysha Sameen; Deog-Hwan Oh
Journal:  Nutrients       Date:  2021-02-21       Impact factor: 5.717

Review 3.  Biomedical features and therapeutic potential of rosmarinic acid.

Authors:  Saba Noor; Taj Mohammad; Malik Abdul Rub; Ali Raza; Naved Azum; Dharmendra Kumar Yadav; Md Imtaiyaz Hassan; Abdullah M Asiri
Journal:  Arch Pharm Res       Date:  2022-04-07       Impact factor: 6.010

Review 4.  Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer's disease: flavonoids and phenols.

Authors:  Meng Zhang; Guanhua Hu; Nan Shao; Yunpeng Qin; Qian Chen; Yan Wang; Peng Zhou; Biao Cai
Journal:  Inflammopharmacology       Date:  2021-08-04       Impact factor: 4.473

5.  Cerebralcare Granule® enhances memantine hydrochloride efficacy in APP/PS1 mice by ameliorating amyloid pathology and cognitive functions.

Authors:  Ou Qiao; Xinyu Zhang; Yi Zhang; Haixia Ji; Zhi Li; Xiaoying Han; Wenzhe Wang; Xia Li; Juan Wang; Changxiao Liu; Wenyuan Gao
Journal:  Chin Med       Date:  2021-06-28       Impact factor: 5.455

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.